FOSAPREPITANT MEDSURGE fosaprepitant (as dimeglumine) 150 mg powder for injection vial

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

fosaprepitant dimeglumine, Quantity: 245.3 mg (Equivalent: fosaprepitant, Qty 150 mg)

Tillgänglig från:

Medsurge Pharma Pty Ltd

Läkemedelsform:

Injection, powder for

Sammansättning:

Excipient Ingredients: disodium edetate; polysorbate 80; hydrochloric acid; sodium hydroxide; lactose

Administreringssätt:

Intravenous Infusion

Enheter i paketet:

1 vial

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

Fosaprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: ? highly emetogenic cancer chemotherapy (see Section 4.2 Dose and Method of Administration) ? moderately emetogenic cancer chemotherapy (see Section 4.2 Dose and Method of Administration).

Produktsammanfattning:

Visual Identification: White-off white lyophilized cake or powder.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Bemyndigande status:

Registered